Financial Performance - Third quarter net sales reached $2.001 billion, a 9.7% increase year-over-year, with an 8.6% increase on a constant currency basis and a 5.0% increase on an organic constant currency basis[2] - Net earnings for the third quarter were $230.9 million, with adjusted net earnings of $377.0 million, resulting in diluted earnings per share of $1.16 and adjusted diluted earnings per share of $1.90, reflecting a 9.2% increase[3][5] - Operating profit for Q3 2025 was $351.3 million, up from $279.5 million in Q3 2024, reflecting a 25.7% increase[34] - Net earnings for Q3 2025 were $230.9 million, compared to $249.1 million in Q3 2024, indicating a decrease of 7.5%[34] - For the nine months ended September 30, 2025, net sales totaled $5,987.7 million, a 5.9% increase from $5,655.4 million in the same period of 2024[37] - The company reported a basic earnings per share of $2.85 for the nine months ended September 30, 2025, down from $3.25 in 2024, a decline of 12.3%[37] - Net earnings for the three months ended September 30, 2025, were $559.3 million, compared to $665.1 million in the same period of 2024, reflecting a decrease of approximately 15.9%[41] - Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) was $1,149.3 million for the nine months ended September 30, 2025[50] - The diluted earnings per share for the three months ended September 30, 2025, was $1.90, compared to $1.16 in the same period of 2024[46] Sales and Revenue Growth - The U.S. business experienced 5.6% organic revenue growth, driven by the adoption of new products known as the 'Magnificent Seven'[6] - The company reported geographic sales of $1.164 billion in the U.S. (10.6% increase) and $837.3 million internationally (8.5% increase) for the third quarter[11] - The S.E.T. product category saw a significant 19.2% increase in sales, totaling $541.5 million for the third quarter[11] - For the three months ended September 30, 2025, the United States market experienced a 10.6% increase in sales, while international sales grew by 8.5%[42] - Net sales for the three months ended September 30, 2025, reached $2,001.4 million, a 9.7% increase from $1,824.2 million in 2024; for the nine months, sales were $5,987.7 million, up from $5,655.4 million[55] Acquisitions and Product Development - The company completed the acquisition of Monogram Technologies, enhancing its portfolio of orthopedic robotics and navigation solutions[8] - The iodine-treated hip implant, the first of its kind, received PMDA approval in Japan and is set to launch soon[6][8] - The company anticipates continued growth driven by new product development and market expansion strategies[30] - The company anticipates continued growth in the orthopedic market, focusing on new product development and market expansion strategies[49] Cash Flow and Assets - Cash and cash equivalents increased to $1,292.7 million as of September 30, 2025, compared to $525.5 million at the end of 2024[39] - Total assets grew to $23,488.0 million as of September 30, 2025, up from $21,365.3 million at the end of 2024, representing a 9.9% increase[39] - The company reported net cash provided by operating activities of $1,179.7 million for the year 2025, an increase of 18.7% from $993.1 million in 2024[41] - The company’s cash and cash equivalents at the end of the period were $1,292.7 million, up from $569.0 million at the end of the previous year[41] Debt and Expenses - The company’s long-term debt increased to $7,512.6 million as of September 30, 2025, compared to $5,341.6 million at the end of 2024, a rise of 40.7%[39] - Research and development expenses for Q3 2025 were $115.9 million, slightly up from $111.6 million in Q3 2024[35] - Research and development expenses reached $339.8 million, while selling, general, and administrative expenses totaled $2,384.9 million[50] - The company incurred $10.9 million in inventory and manufacturing-related charges for the three months ended September 30, 2025, compared to $9.4 million in 2024[56] Market Challenges and Recognition - The company is addressing weaknesses in Latin America, Emerging Markets in Europe, and non-core businesses that emerged late in the quarter[6] - The company was recognized by Fortune as one of the best 100 companies to work for in Europe[8] - The company initiated global restructuring programs in December 2019, 2021, and 2023, aimed at reducing costs and accelerating decision-making[2] - The company has excluded various litigation charges from its non-GAAP financial measures, which can vary significantly in their impact on operating results[4]

Ø Overview Bunge Reports Third Quarter 2025 Results Greg Heckman, Bunge's Chief Executive Officer said, "In our first full quarter since closing the Viterra transaction, our combined team delivered strong results in a complex market and regulatory environment across nearly all regions. We're beginning to realize the benefits of our expanded global platform. By aligning the business around our proven end-to-end value chain model, we're unlocking efficiencies—optimizing our footprint, coordinating larger flow ...

Financial Performance - Revenues for the three months ended September 30, 2025, were $496.764 million, a 14.7% increase from $433.012 million in the same period of 2024[116] - Gross profit for the same period was $139.019 million, compared to $132.877 million in 2024, reflecting a growth of 4.6%[116] - The net income for Q3 2025 was $5.244 million, a significant recovery from a net loss of $6.454 million in Q3 2024[116] - Adjusted EBITDA for the three months ended September 30, 2025, was $48.223 million, slightly up from $47.927 million in the same period of 2024[116] - Non-GAAP Net Income for the three months ended September 30, 2025, was $34,263 thousand, compared to $22,211 thousand in 2024, reflecting a significant increase of 54.3%[133] - For the nine months ended September 30, 2025, revenues increased by $114.6 million, or 9.0%, compared to the same period in 2024, primarily due to an increase in the number of Scaled Advertisers[165] - Gross profit for the nine months ended September 30, 2025, increased by $37.3 million, or 10.5%, compared to the same period in 2024[166] Client and Revenue Metrics - The number of Scaled Advertiser clients increased to approximately 2,100 in Q3 2025, up from 2,000 in Q3 2024, representing a 5% growth[110] - Average Revenue per Scaled Advertiser rose to approximately $208,000 in Q3 2025, compared to $187,000 in Q3 2024, marking an increase of 11.2%[110] - Revenue contribution from Scaled Advertisers accounted for 86% of total revenues in Q3 2025, up from 85% in Q3 2024[110] - Revenues increased by $63.8 million, or 14.7%, for the three months ended September 30, 2025, compared to the same period in 2024, driven by a 10.9% increase in Average Revenue per Scaled Advertiser and a 4.4% increase in the number of Scaled Advertisers[153] Cash Flow and Operating Activities - Cash flow provided by operating activities was $53.203 million for Q3 2025, compared to $49.772 million in Q3 2024, indicating a growth of 4.3%[116] - Free Cash Flow for the nine months ended September 30, 2025, was $116.520 million, compared to $97.266 million in the same period of 2024, showing a growth of 19.8%[116] - Net cash provided by operating activities was $148.7 million for the nine months ended September 30, 2025, an increase of $26.3 million compared to $122.4 million for the same period in 2024[184] Costs and Expenses - Total cost of revenues increased by $57.6 million, or 19.2%, for the three months ended September 30, 2025, compared to the same period in 2024[156] - Traffic acquisition cost for the three months ended September 30, 2025, was $324,079 thousand, which is a 20.8% increase from $267,997 thousand in 2024[123] - Research and development expenses increased by $5.0 million, or 4.7%, mainly due to a $5.8 million increase in salaries and related expenses[170] - Sales and marketing expenses increased by $7.0 million, or 3.5%, primarily due to a $5.2 million increase in advertising and promotion expenses related to the launch of Realize[171] - General and administrative expenses increased by $3.7 million, or 5.2%, mainly due to a $2.5 million increase in professional fees[172] Shareholder and Financing Activities - The company repurchased 58.3 million shares at an average price of $3.15 per share during the nine months ended September 30, 2025[181] - Net cash used in financing activities was $236.5 million, an increase of $174.2 million compared to $62.3 million in the same period in 2024, primarily due to $184.6 million repurchase of shares[192] Financial Position and Risks - As of September 30, 2025, the company had $115.5 million in cash and cash equivalents, down from $226.6 million as of December 31, 2024[177] - The company has a provision related to unrecognized tax benefit liabilities totaling $11.5 million as of September 30, 2025[196] - A 10% increase in the NIS against the U.S. dollar would result in a $1,260 thousand increase in operating income, while a 10% decrease would lead to a $220 thousand loss[201] - Inflation has resulted in higher equipment and labor costs, which could adversely affect the company's financial condition if not effectively mitigated[206] Accounting and Compliance - There have been no material changes to the company's critical accounting policies and estimates for the year ended December 31, 2024[200] - The company does not require collateral for accounts receivable, and historically has not experienced material losses related to receivables from advertisers[207] - As of September 30, 2025, no single customer accounted for 10% or more of accounts receivable or total revenue[208]

Financial Performance - Third quarter 2025 net income attributable to Targa Resources Corp. was $478.4 million, a 23.5% increase from $387.4 million in the third quarter of 2024[3]. - Adjusted EBITDA for the third quarter of 2025 reached a record $1,274.8 million, representing a 19% year-over-year increase and a 10% increase compared to the second quarter of 2025[7][8]. - Targa estimates full year 2025 adjusted EBITDA to be around the top end of the $4.65 billion to $4.85 billion range[16]. - Total revenues rose by $299.4 million (8%) to $4,151.2 million for the three months ended September 30, 2025, compared to $3,851.8 million in 2024[23]. - Adjusted EBITDA for the nine months ended September 30, 2025, was $3,616.3 million, compared to $3,020.3 million in 2024[67]. - Estimated net income attributable to Targa Resources Corp. for 2025 is projected at $1,825 million[70]. - Estimated Adjusted EBITDA for 2025 is projected to be $4,850 million, reflecting significant contributions from interest expense, depreciation, and other adjustments[70]. Shareholder Returns - Targa repurchased 932,023 shares of common stock at a total cost of $155.6 million during the third quarter of 2025, with $1,410.6 million remaining under the Share Repurchase Programs as of September 30, 2025[6][19]. - The company expects to recommend a 25% increase in the annual common dividend per share to $5.00 for 2026, up from $4.00 in 2025[7][17]. - For the nine months ended September 30, 2025, Targa repurchased 3,538,285 shares at a total cost of $604.8 million[18]. Operational Developments - The company commenced operations at its new 275 MMcf/d Bull Moose II plant in the Permian Delaware in October 2025[7][11]. - Targa announced plans to construct the Speedway NGL Pipeline and Buffalo Run, enhancing connectivity in the Permian region, with expected completion dates in 2027 and 2028 respectively[14][15]. - The company plans to detail its full year 2026 operational and financial outlook in February 2026[20]. - The company added multiple plants in the Permian, including the Pembrook II plant in Q3 2025, contributing to increased natural gas inlet volumes[45]. Revenue Drivers - Commodity sales increased by $252.9 million (8%) to $3,469.9 million for the three months ended September 30, 2025, compared to $3,217.0 million in 2024, driven by higher natural gas prices and NGL volumes[23][24]. - The increase in fees from midstream services was primarily due to higher gas gathering and processing fees, contributing to overall revenue growth[24][31]. - The average realized price for natural gas increased significantly to $1.20 per MMBtu, compared to $0.09 per MMBtu in the same quarter of 2024, marking a 169% increase[40]. Cost and Expenses - Operating expenses increased by $32.5 million (11%) to $333.5 million for the three months ended September 30, 2025, primarily due to higher maintenance, taxes, and labor costs[26][32]. - Interest expense, net, rose by $36.4 million (20%) to $221.3 million for the three months ended September 30, 2025, due to higher borrowings[28][34]. - Operating expenses for the nine months ended September 30, 2025, increased by $26.0 million, or 10%, to $299.5 million compared to $273.5 million in 2024[50]. Production and Volumes - Natural gas inlet volumes in the Permian increased by 677.2 MMcf/d, representing an 11% increase compared to the same period in 2024[40]. - The total NGL production for the three months ended September 30, 2025, was 1,095.1 MBbl/d, a 12% increase from 978.2 MBbl/d in 2024[40]. - Pipeline transportation volumes rose by 23% to 1,017.0 MBbl/d in Q3 2025, up from 829.2 MBbl/d in Q3 2024[50]. - Fractionation volumes increased by 19% to 1,134.3 MBbl/d in Q3 2025, compared to 953.8 MBbl/d in Q3 2024[50]. Forward-Looking Statements and Risks - Forward-looking statements indicate potential risks including commodity price volatility and changes in market conditions[72]. - The company does not undertake an obligation to update or revise any forward-looking statements[72]. - The company emphasizes the importance of monitoring its website for material disclosures and updates[71].

n e w s r e l e a s e Exhibit 99.2 Humana Inc. 500 West Main Street P.O. Box 1438 Louisville, KY 40202 http://www.humana.com FOR MORE INFORMATION CONTACT: Lisa Stoner Humana Investor Relations (502) 580-2652 e-mail: LStamper@humana.com Mark Taylor Humana Corporate Communications (317) 753-0345 e-mail: MTaylor108@humana.com Humana Reports Third Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted EPS Guidance LOUISVILLE, KY (November 5, 2025) – Humana Inc. (NYSE: HUM) today reported consolidated p ...

Financial Performance - In Q3 2025, the company's operating revenue was $880.1 million, down 8.5% from $962.0 million in Q3 2024[98]. - Operating income for Q3 2025 was $161.0 million, a decrease of 33.6% compared to $242.3 million in Q3 2024[98]. - The company's net income for Q3 2025 was $134.7 million, down 32.3% from $199.1 million in Q3 2024[98]. - For full year 2025, the company expects operating income to be approximately 30% lower than the $147.5 million achieved in Q4 2024[94]. - Ocean Transportation revenue decreased by $80.4 million, or 10.1%, to $718.3 million for the three months ended September 30, 2025, compared to $798.7 million in the same period of 2024[109]. - Operating income for Ocean Transportation fell by $79.5 million, or 35.0%, to $147.4 million for the three months ended September 30, 2025, down from $226.9 million in 2024[111]. - Logistics revenue decreased by $1.5 million, or 0.9%, to $161.8 million for the three months ended September 30, 2025, compared to $163.3 million in 2024[120]. - Operating income for Logistics dropped by $1.8 million, or 11.7%, to $13.6 million for the three months ended September 30, 2025[121]. - Ocean Transportation revenue for the nine months ended September 30, 2025, decreased by $36.3 million, or 1.8%, to $2,031.3 million compared to $2,067.6 million in 2024[116]. - Logistics operating income for the nine months ended September 30, 2025, decreased by $3.8 million, or 9.4%, to $36.5 million compared to $40.3 million in 2024[125]. Container Volume - Container volume in Hawaii increased by 0.3% year-over-year in Q3 2025, while in China, it decreased by 12.8% due to ongoing trade uncertainties[85][86]. - Hawaii container volume increased by 0.3% to 36,300 FEUs, while China container volume decreased by 12.8% to 34,900 FEUs for the three months ended September 30, 2025[110]. Cash Flow and Capital Management - Cash and cash equivalents decreased by $174.1 million to $92.7 million as of September 30, 2025, compared to $266.8 million at the end of 2024[126]. - Net cash provided by operating activities fell by $222.9 million to $370.2 million for the nine months ended September 30, 2025, compared to $593.1 million in 2024[127]. - The Company had a working capital deficit of $93.5 million as of September 30, 2025, compared to a surplus of $49.2 million at December 31, 2024[133]. - Total Debt decreased by $30.0 million to $370.9 million as of September 30, 2025, due to scheduled fixed interest debt repayments[135]. - The Company repurchased approximately 2.0 million shares for a total cost of $229.3 million during the nine months ended September 30, 2025, compared to 1.4 million shares for $169.2 million in the same period of 2024[139]. - The Company paid $225.8 million to repurchase Matson common stock during the nine months ended September 30, 2025, up from $167.4 million in the prior year[132]. - The Company paid $33.7 million in dividends during the nine months ended September 30, 2025, compared to $33.5 million in the same period of 2024[132]. - CCF cash and cash equivalents increased to $376.7 million as of September 30, 2025, from $230.7 million at December 31, 2024[134]. - The Company made milestone payments of $136.5 million under vessel construction agreements during the nine months ended September 30, 2025, compared to $35.8 million in the same period of 2024[138]. - The Company has $544.0 million of remaining borrowing availability under the revolving credit facility as of September 30, 2025[137]. Tax and Interest - The effective tax rate for Q3 2025 was 20.2%, with an expected rate of approximately 22.0% for the full year 2025[96]. - Interest income for the full year 2025 is expected to be approximately $32 million, while interest expense is projected to be around $7 million[95]. Joint Ventures - The contribution from the SSAT joint venture in Q3 2025 was $9.3 million, an increase of $2.4 million from Q3 2024[91]. - The Company's SSAT terminal joint venture investment contributed $23.2 million during the nine months ended September 30, 2025, up from $8.5 million in the same period of 2024[119]. Future Outlook - The company anticipates full year 2025 depreciation and amortization expense to be around $196 million[94]. - The Company declared a cash dividend of $0.36 per share payable on December 4, 2025[143]. - The Company intends to use CCF cash and cash equivalents to fund future milestone payments for the construction of three new Aloha Class vessels[138].

Financial Performance - Net loss from continuing operations attributable to Owens Corning was $(495) million in Q3 2025, compared to $287 million in Q3 2024[232]. - Adjusted EBITDA from continuing operations for Q3 2025 was $638 million, down from $705 million in Q3 2024[232]. - Net sales for Q3 2025 decreased by $79 million to $2,684 million, while year-to-date sales increased by $684 million to $7,961 million[241][243]. - Gross margin for Q3 2025 was $757 million, a decrease of $94 million compared to Q3 2024, with a margin percentage of 28%[241][244]. - Adjusted EBITDA from continuing operations for the first nine months of 2025 was $1,906 million, slightly up from $1,898 million in the same period of 2024[255]. - Corporate, Other and Eliminations segment reported an EBITDA loss of $837 million in Q3 2025, significantly impacted by a goodwill impairment charge of $780 million[276][277]. Goodwill and Impairment - The Company recorded a non-cash goodwill impairment charge of $780 million in Q3 2025 related to the Doors reporting unit[233][246]. - The remaining balance of goodwill for the Doors reporting unit is $732 million as of September 30, 2025, which remains at risk for future impairment[320]. - No impairment was determined for the indefinite-lived tradename used by the Doors reporting unit after an interim impairment test[321]. - The Company performed a recoverability test for a certain asset group within the Doors segment, which was determined to be recoverable[323]. - The fair value used in testing for potential impairment of the tradename was calculated using the relief-from-royalty method[322]. - A 1% decrease in base year revenue would decrease fair value by approximately 1%, while a 1% decrease in revenue growth rates would decrease fair value by approximately 4%[319]. Expenses and Costs - Marketing and administrative expenses decreased by $18 million to $240 million in Q3 2025, but increased by $87 million year-to-date[241][245]. - Interest expense for Q3 2025 was $65 million, a decrease of $4 million compared to Q3 2024[241][248]. - Income tax expense for Q3 2025 was $102 million, with an effective tax rate of (26%) due to non-deductible goodwill impairment[249]. - General corporate expenses for 2025 are estimated to be approximately $240 million[279]. Sales and Segments - Roofing segment net sales increased by $19 million (2%) year-over-year in Q3 2025, driven by higher selling prices of $37 million, despite lower volumes[258][259]. - Insulation segment net sales decreased by $67 million (7%) in Q3 2025, primarily due to lower sales volumes of approximately 5% and a $33 million unfavorable impact from divestitures[263][264]. - Doors segment net sales decreased by $28 million (5%) in Q3 2025, attributed to lower volumes and selling prices, but year-to-date sales increased by $755 million (85%) due to the acquisition of Masonite[271][272]. Cash Flow and Liquidity - The Company had cash and cash equivalents of $286 million as of September 30, 2025, as part of its liquidity resources[280]. - Cash and cash equivalents decreased to $343 million as of September 30, 2025, down from $499 million a year earlier[286]. - Net cash flow from operating activities decreased by $20 million for the nine months ended September 30, 2025, compared to the same period in 2024[287]. - Net cash flow used for investing activities decreased by $2,680 million for the nine months ended September 30, 2025, primarily due to the Masonite acquisition in the prior year[288]. - Net cash flow used for financing activities increased by $1,684 million for the nine months ended September 30, 2025, driven by higher net proceeds from long-term debt related to the Masonite acquisition[289]. - The Company expects cash on hand, future cash flows, and available liquidity sources to meet anticipated cash requirements[290]. Debt and Financing - As of September 30, 2025, the Company had $5.2 billion in total debt, including $399 million of 3.4% senior notes maturing in Q3 2026[292]. - The Company has a $1.5 billion Senior Revolving Credit Facility, amended in March 2025 to increase the borrowing limit from $1.0 billion and extend the maturity to March 2030[281]. - The Company established a CP Program for issuing $1.5 billion in unsecured commercial paper notes with maturities up to 397 days[283]. - The Company had $40 million of CP Notes outstanding as of September 30, 2025, with a weighted average interest rate of 4.25%[294]. Operational Outlook - The Company expects to partially offset the impact of new tariffs through supply chain adjustments and productivity actions[240]. - The Company expects non-discretionary residential re-roof and remodeling activity to moderate in the near term, influenced by competitive pricing pressure and raw material costs[262]. - Insulation demand outlook is closely tied to North American residential construction and remodeling activity, with current housing starts at approximately 1.330 million, a slight increase from 1.326 million in Q3 2024[268][269]. Share Repurchase - The Company repurchased 3.8 million shares of its common stock for $545 million during the nine months ended September 30, 2025[339]. - As of September 30, 2025, 14.6 million shares remain available for repurchase under the Repurchase Authorizations[339]. Safety Metrics - The Recordable Incident Rate (RIR) for the three months ended September 30, 2025, was 0.56, compared to 0.58 in the same period a year ago[304]. Management and Controls - The Company’s management concluded that the disclosure controls and procedures are effective as of the end of the reporting period[331].

Financial Performance - Net revenue from continuing operations increased by 7.9% to $487.3 million in Q3 2025 compared to Q3 2024[6] - Comparable store sales growth was 6.8%, marking the 11th consecutive quarter of positive growth[6] - Adjusted Operating Income from continuing operations rose by 38.6% to $19.8 million, with an Adjusted Operating Margin improving to 4.1%[6] - Total net revenue for the three months ended September 27, 2025, was $487.33 million, a 7.9% increase from $451.52 million in the same period of 2024[35] - Net product sales reached $393.48 million, up 8.3% from $363.16 million year-over-year[35] - Net income for the nine months ended September 27, 2025, was $26.28 million, compared to $0.09 million in the same period of 2024[37] - Operating cash flow for the nine months ended September 27, 2025, was $133.13 million, an increase from $103.37 million in the prior year[37] - Net income for the three months ended September 27, 2025, was $3,372,000, compared to a loss of $8,468,000 for the same period in 2024, marking a significant turnaround[39] Outlook and Projections - The fiscal 2025 outlook for net revenue has been raised to a range of $1.970 billion to $1.988 billion, up from the previous estimate[11] - Adjusted Diluted EPS is projected to increase to a range of $0.63 to $0.71 for fiscal 2025, compared to the prior outlook[11] - The 2025 Outlook projects total comparable store sales growth from continuing operations to be between 5.5% and 6.5%[48] Store Operations - The company opened four new America's Best stores, ending the quarter with a total of 1,242 stores, reflecting a 0.9% increase in store count[7] - Comparable store sales growth from continuing operations for the three months ended September 27, 2025, was 6.8%, compared to 1.4% for the same period in 2024[48] - Adjusted Comparable Store Sales Growth from continuing operations for the nine months ended September 27, 2025, was 6.4%, up from 1.2% in the same period in 2024[48] - The Owned & Host segment's America's Best reported a comparable store sales growth of 8.1% for the three months ended September 27, 2025[48] - Eyeglass World experienced a comparable store sales growth of 5.2% for the three months ended September 27, 2025, compared to a decline of 0.9% in the same period in 2024[48] - Military segment reported a comparable store sales growth of 4.4% for the three months ended September 27, 2025[48] - Fred Meyer showed a comparable store sales growth of 4.1% for the three months ended September 27, 2025, recovering from a decline of 7.3% in the same period in 2024[48] - Adjusted Comparable Store Sales Growth from continuing operations for the three months ended September 27, 2025, was 7.7%, compared to 0.9% in the same period in 2024[48] Cost and Expenses - Costs applicable to revenue increased by 7.0% to $203.2 million, while the percentage of net revenue decreased to 41.7%[10] - The company incurred total operating expenses of $274.52 million for the three months ended September 27, 2025, compared to $270.41 million in the same period of 2024[35] - Long-term debt repayments amounted to $94.71 million for the nine months ended September 27, 2025, compared to $218.75 million in the same period of 2024[37] - Interest expense for the nine months ended September 27, 2025, was $12,901,000, compared to $11,560,000 for the same period in 2024, reflecting an increase of approximately 11.6%[39] - The company incurred stock-based compensation expenses of $17,836,000 for the nine months ended September 27, 2025, compared to $11,779,000 for the same period in 2024, indicating increased compensation costs[39] Non-GAAP Measures - The company utilizes non-GAAP financial measures such as EBITDA, Adjusted Operating Income, and Adjusted Diluted EPS to provide a clearer picture of its operational performance[19] - Adjusted Operating Income excludes various expenses like stock-based compensation and litigation settlements, providing a more accurate reflection of core operations[22] - Adjusted Operating Margin is calculated as Adjusted Operating Income as a percentage of total net revenue, highlighting operational efficiency[23] - Adjusted EBITDA is similarly defined, excluding specific expenses to focus on ongoing operational performance[24] - Adjusted SG&A is calculated by excluding certain expenses, providing insight into the company's operational cost structure[27] - The company emphasizes that non-GAAP measures should not be viewed as alternatives to GAAP measures, as they have limitations and may not be comparable across companies[30] - The company is committed to transparency by providing reconciliations of non-GAAP to GAAP financial measures in its reports[31] Tax and Liabilities - The company reported an income tax provision of $13,010,000 for the nine months ended September 27, 2025, compared to $2,239,000 for the same period in 2024, indicating a significant increase in tax obligations[39] - Total current assets decreased to $220.19 million as of September 27, 2025, from $249.83 million as of December 28, 2024[34] - Total liabilities decreased to $1.1 billion as of September 27, 2025, from $1.2 billion as of December 28, 2024[34] - Cash and cash equivalents at the end of the period were $57.57 million, down from $82.68 million a year earlier[37]

Revenue Performance - Third-quarter 2025 revenue reached $357.8 million, reflecting a 12.5% increase on a reported basis and 11.0% on a constant-currency basis compared to the prior year[4] - Cardiopulmonary revenue increased by 18.0% on a reported basis and 15.9% on a constant-currency basis, driven by sales of the Essenz Perfusion System and strong consumables demand[6] - Neuromodulation revenue grew by 6.9% on a reported basis and 6.4% on a constant-currency basis, with growth across all regions[6] - Net revenue for Q3 2025 was $357.8 million, a 12.5% increase from $318.1 million in Q3 2024[26] - Cardiopulmonary segment revenue increased by 18.0% year-over-year, reaching $203.2 million, with U.S. revenue growing by 15.1% to $71.9 million[26] - Neuromodulation segment revenue grew by 6.9% year-over-year to $149.5 million, with U.S. revenue increasing by 4.9% to $118.4 million[26] - For the nine months ended September 30, 2025, net revenue was $1,027.1 million, a 10.3% increase from $931.6 million in the same period of 2024[35] - Organic net revenue for the nine months ended September 30, 2025, was $1,027.1 million, reflecting an 11.1% increase from $920.1 million in the same period of 2024[52] Earnings and Profitability - Adjusted diluted earnings per share for the third quarter of 2025 was $1.11, up from $0.90 in the same quarter of 2024[8] - Adjusted diluted earnings per share guidance for 2025 increased to a range of $3.80 to $3.90, up from $3.70 to $3.80[10] - Adjusted free cash flow for 2025 is now expected to be between $160 million and $180 million, an increase from the previous range of $140 million to $160 million[10] - Operating income for the third quarter of 2025 was $54.0 million, compared to $35.6 million in the same quarter of 2024[7] - Net income for Q3 2025 decreased to $26.8 million from $33.0 million in Q3 2024, with diluted earnings per share at $0.49[32] - For the three months ended September 30, 2025, the adjusted net income was $61.4 million, representing a 17.2% margin on net revenue[37] - The diluted EPS for the same period was $1.11, reflecting an increase from the previous year[37] - For the nine months ended September 30, 2025, the company reported a gross profit of $317.7 million, with a gross margin of 69.1%[41] - The net loss for the nine months was $166.9 million, translating to a net loss margin of 16.3%[41] - Diluted EPS for the period was reported at ($5.01)[41] Expenses and Margins - Gross profit margin for Q3 2025 was 68.4%, slightly down from 69.5% in Q3 2024[32] - Operating income for Q3 2025 was $80.4 million, with an operating margin of 22.5%[37] - Research and development expenses decreased to $45.0 million, accounting for 12.6% of net revenue[37] - Selling, general, and administrative expenses were $122.8 million, representing 34.3% of net revenue, down from 38.7%[37] - The cost of sales for Q3 2025 was $112.9 million, leading to a gross profit of $109.5 million[37] - Selling, general, and administrative expenses totaled $359.9 million, representing 35.0% of net revenue[41] - Research and development expenses were $127.2 million, accounting for 12.4% of net revenue[41] - The operating income margin improved from 19.7% in the previous year to 21.6% in 2025[44] Cash Flow and Financial Position - Net cash provided by operating activities for the third quarter was $85.1 million, with adjusted free cash flow of $62.0 million[4] - Net cash provided by operating activities for the nine months ended September 30, 2025, was $171.9 million, up from $104.3 million in the same period of 2024, representing a 64.6% increase[50] - Adjusted free cash flow for the three months ended September 30, 2025, was $62.0 million, after accounting for $22.9 million in capital expenditures[53] - The company’s cash and cash equivalents at the end of the period were $646.1 million, a decrease from $666.6 million at the end of September 2024[50] - Long-term debt obligations decreased to $349.0 million as of September 30, 2025, down from $549.6 million at December 31, 2024, a reduction of 36.5%[47] Future Outlook and Strategic Initiatives - Full-year 2025 revenue growth guidance raised to 8.5% to 9.5% on a constant-currency basis and 9.5% to 10.5% on an organic basis[9] - The Essenz Perfusion System was commercially launched in China, the second-largest market for heart-lung machines[4] - Future outlook includes continued focus on R&D and potential market expansion strategies[43] - The company incurred restructuring expenses related to organizational changes and impairment of investments, impacting overall financial performance[46] Balance Sheet and Liabilities - Total assets increased to $2,557.6 million as of September 30, 2025, compared to $2,506.4 million at December 31, 2024, reflecting a growth of 2.0%[47] - Total current liabilities surged to $827.6 million as of September 30, 2025, from $392.1 million at December 31, 2024, indicating a significant increase of 111.4%[47] - The income tax rate for the nine months ended September 30, 2025, was (10.0)%, compared to 76.9% for the same period in 2024[51]

Exhibit 99.1 Taboola Reports Strong Q3 2025 Financial Results, Surpassing High-End of Guidance; Raises Full-Year Outlook NEW YORK, Nov. 5, 2025 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced its results for the third quarter ended September 30, 2025. "We delivered another strong quarter with our third quarter results beating the high-end of our guidance across all metrics" said Adam Singolda, CEO of Taboola. "Realize is at an i ...